Palantir faces a $330 million test U.S. investors should watch closely
Palantir Technologies (PLTR) has a rapidly growing U.S. business. But a £330 million ($447 million) NHS contract in Britain is giving investors another issue to watch: what happens when the company’s expansion into foreign governments meets political resistance?
24 Sep 01:03 · The Fresno Bee